Terms: = Lung cancer AND MECOM, MDS1-EVI1, EVI1, 2122, ENSG00000085276, Q03112, PRDM3
53 results:
1. mecom: a bioinformatics and experimentally identified marker for the diagnosis and prognosis of lung adenocarcinoma.
Li A; Li M; Wang J; Zhou J; Yang T; Fan M; Zhang K; Gao H; Ren H; Chen M
Biomark Med; 2024 Jan; 18(2):79-91. PubMed ID: 38440890
[TBL] [Abstract] [Full Text] [Related]
2. Disease patterns and specific trajectories of anti-MDA5-related disease: a multicentre retrospective study of 70 adult patients.
de Boysson H; Cuchet M; Cassius C; Cuchet P; Agard C; Audemard-Verger A; Marchand-Adam S; Cohen-Sors R; Gallay L; Graveleau J; Lesort C; Ly K; Meyer A; Monseau G; Néel A; Bonnotte B; Pérard L; Schleinitz N; Mariotte D; Le Mauff B; Bourdenet G; Masmoudi W; Deshayes S; Dumont A; Dompmartin A; Kottler D; Aouba A
Front Immunol; 2023; 14():1319957. PubMed ID: 38259447
[TBL] [Abstract] [Full Text] [Related]
3. Heat shock protein B7 (HSPB7) inhibits lung adenocarcinoma progression by inhibiting glycolysis.
Chen Z; Li P; Shen L; Jiang X
Oncol Rep; 2023 Nov; 50(5):. PubMed ID: 37732539
[TBL] [Abstract] [Full Text] [Related]
4. The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, lung, or Ovarian cancer.
Mattox AK; Douville C; Wang Y; Popoli M; Ptak J; Silliman N; Dobbyn L; Schaefer J; Lu S; Pearlman AH; Cohen JD; Tie J; Gibbs P; Lahouel K; Bettegowda C; Hruban RH; Tomasetti C; Jiang P; Chan KCA; Lo YMD; Papadopoulos N; Kinzler KW; Vogelstein B
Cancer Discov; 2023 Oct; 13(10):2166-2179. PubMed ID: 37565753
[TBL] [Abstract] [Full Text] [Related]
5. Frequent EGFR exon 20 insertion in the so-called peripheral-type squamous cell neoplasm of uncertain malignant potential: a variant of bronchiolar adenoma or under-recognised entity?
Zheng Q; Hou L; Shang G; Qi X; Zhang M; Jin Y; Wang Y; Xue Q; Wu C; Li Y
Histopathology; 2023 Aug; 83(2):178-192. PubMed ID: 36864007
[TBL] [Abstract] [Full Text] [Related]
6. Clinicopathological Features and Prognosis of Gastrointestinal Metastases From Breast Carcinoma: A Clinicopathological Study of 22 Patients.
Wang S; Li W; Li S; Liu X; Zhang L; Hao C; Meng W; Zhao W; Tong Z
Int J Surg Pathol; 2023 Sep; 31(6):1075-1084. PubMed ID: 36803140
[No Abstract] [Full Text] [Related]
7. Integrative weighted molecular network construction from transcriptomics and genome wide association data to identify shared genetic biomarkers for COPD and lung cancer.
Banaganapalli B; Mallah B; Alghamdi KS; Albaqami WF; Alshaer DS; Alrayes N; Elango R; Shaik NA
PLoS One; 2022; 17(10):e0274629. PubMed ID: 36194576
[TBL] [Abstract] [Full Text] [Related]
8. CRISPR-mediated mecom depletion retards tumor growth by reducing cancer stem cell properties in lung squamous cell carcinoma.
Ma Y; Kang B; Li S; Xie G; Bi J; Li F; An G; Liu B; Li J; Shen Y; Xu X; Yang H; Yang Y; Gu Y; Wu N
Mol Ther; 2022 Nov; 30(11):3341-3357. PubMed ID: 35733338
[TBL] [Abstract] [Full Text] [Related]
9. Molecular yield and cytomorphologic assessment of fine needle aspiration specimen supernatants.
Ruff HM; Lou SK; Hahn E; Grenier S; Stockley TL; Boerner SL
J Am Soc Cytopathol; 2022; 11(3):142-153. PubMed ID: 35305954
[TBL] [Abstract] [Full Text] [Related]
10. Synthesis and receptor dependent 4D-QSAR studies of 4,5-dihydro-1,3,4-oxadiazole derivatives targeting cannabinoid receptor.
Hu ZH; Zhao TS; Liu HY; Lin QX; Tu GG; Yang BW
SAR QSAR Environ Res; 2021 Mar; 32(3):175-190. PubMed ID: 33618568
[TBL] [Abstract] [Full Text] [Related]
11. Role of miR-96/evi1/miR-449a Axis in the Nasopharyngeal Carcinoma Cell Migration and Tumor Sphere Formation.
Chan LS; Lung HL; Ngan RK; Lee AW; Tsao SW; Lo KW; Kahn M; Lung ML; Wieser R; Mak NK
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32752071
[TBL] [Abstract] [Full Text] [Related]
12. Computed tomography fluoroscopy-guided cutting needle biopsy of pulmonary nodules ≤8 mm: A retrospective study including 117 nodules.
Zhao Y; Matsui Y; Hiraki T; Iguchi T; Tomita K; Uka M; Gobara H; Toyooka S; Kanazawa S
Eur J Radiol; 2020 Apr; 125():108903. PubMed ID: 32088660
[TBL] [Abstract] [Full Text] [Related]
13. evi1 as a Marker for Lymph Node Metastasis in HNSCC.
Idel C; Ribbat-Idel J; Kuppler P; Krupar R; Offermann A; Vogel W; Rades D; Kirfel J; Wollenberg B; Perner S
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013033
[TBL] [Abstract] [Full Text] [Related]
14. Potential Diagnostic and Prognostic Biomarkers of Circular RNAs for lung cancer in China.
Wang C; Jiang Y; Lei Q; Wu Y; Shao J; Pu D; Li W
Biomed Res Int; 2019; 2019():8023541. PubMed ID: 31534962
[TBL] [Abstract] [Full Text] [Related]
15. Near-infrared dye marking for thoracoscopic resection of small-sized pulmonary nodules: comparison of percutaneous and bronchoscopic injection techniques.
Anayama T; Hirohashi K; Miyazaki R; Okada H; Kawamoto N; Yamamoto M; Sato T; Orihashi K
J Cardiothorac Surg; 2018 Jan; 13(1):5. PubMed ID: 29329549
[TBL] [Abstract] [Full Text] [Related]
16. Propensity score-matched outcomes after thoracic epidural or paravertebral analgesia for thoracotomy.
Blackshaw WJ; Bhawnani A; Pennefather SH; Al-Rawi O; Agarwal S; Shaw M
Anaesthesia; 2018 Apr; 73(4):444-449. PubMed ID: 29327462
[TBL] [Abstract] [Full Text] [Related]
17. The burden of neutropenic sepsis in patients with advanced non-small cell lung cancer treated with single-agent docetaxel: A retrospective study.
Talbot T; Dangoor A; Shah R; Naik J; Talbot D; Lester JF; Cipelli R; Hodgson M; Patel A; Summerhayes M; Newsom-Davis T
Lung Cancer; 2017 Nov; 113():115-120. PubMed ID: 29110837
[TBL] [Abstract] [Full Text] [Related]
18. The Synthetic Cannabinoid WIN 55,212-2 Elicits Death in Human cancer Cell Lines.
Müller L; Radtke A; Decker J; Koch M; Belge G
Anticancer Res; 2017 Nov; 37(11):6341-6345. PubMed ID: 29061818
[TBL] [Abstract] [Full Text] [Related]
19. SHOULD WE BE CONCERNED ABOUT THE DOSES OF IONIZING RADIATION RELATED TO DIAGNOSTIC AND FOLLOW-UP IMAGING IN PATIENTS WITH SOLITARY PULMONARY NODULES?
Dabrowska M; Przybylo Z; Zukowska M; Kobylecka M; Maskey-Warzechowska M; Krenke R
Radiat Prot Dosimetry; 2018 Jan; 178(2):201-207. PubMed ID: 28981871
[TBL] [Abstract] [Full Text] [Related]
20. Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition.
Mateo F; Arenas EJ; Aguilar H; Serra-Musach J; de Garibay GR; Boni J; Maicas M; Du S; Iorio F; Herranz-Ors C; Islam A; Prado X; Llorente A; Petit A; Vidal A; Català I; Soler T; Venturas G; Rojo-Sebastian A; Serra H; Cuadras D; Blanco I; Lozano J; Canals F; Sieuwerts AM; de Weerd V; Look MP; Puertas S; García N; Perkins AS; Bonifaci N; Skowron M; Gómez-Baldó L; Hernández V; Martínez-Aranda A; Martínez-Iniesta M; Serrat X; Cerón J; Brunet J; Barretina MP; Gil M; Falo C; Fernández A; Morilla I; Pernas S; Plà MJ; Andreu X; Seguí MA; Ballester R; Castellà E; Nellist M; Morales S; Valls J; Velasco A; Matias-Guiu X; Figueras A; Sánchez-Mut JV; Sánchez-Céspedes M; Cordero A; Gómez-Miragaya J; Palomero L; Gómez A; Gajewski TF; Cohen EEW; Jesiotr M; Bodnar L; Quintela-Fandino M; López-Bigas N; Valdés-Mas R; Puente XS; Viñals F; Casanovas O; Graupera M; Hernández-Losa J; Ramón Y Cajal S; García-Alonso L; Saez-Rodriguez J; Esteller M; Sierra A; Martín-Martín N; Matheu A; Carracedo A; González-Suárez E; Nanjundan M; Cortés J; Lázaro C; Odero MD; Martens JWM; Moreno-Bueno G; Barcellos-Hoff MH; Villanueva A; Gomis RR; Pujana MA
Oncogene; 2017 May; 36(19):2737-2749. PubMed ID: 27991928
[TBL] [Abstract] [Full Text] [Related]
[Next]
